Caisse de Depot et Placement du Quebec (CDPQ)’s Legend Biotech LEGN Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Sell	8,316 -7,900	-49%	-$213K	﹤0.01%	701
2026 Q1	$293K	Sell	16,216 -14,562	-47%	-$278K	﹤0.01%	671
2025 Q4	$669K	Buy	30,778 +4,478	+17%	+$128K	﹤0.01%	534
2025 Q3	$858K	Buy	+26,300	New	+$971K	﹤0.01%	525
2023 Q2	–	Sell	-175	Closed	-$8.44K	–	520
2023 Q1	$8.44K	Sell	175 -9,478	-98%	-$464K	﹤0.01%	534
2022 Q4	$482K	Sell	9,653 -8,200	-46%	-$397K	﹤0.01%	541
2022 Q3	$728K	Buy	17,853 +328	+2%	+$15.4K	﹤0.01%	498
2022 Q2	$964K	Buy	17,525 +9,100	+108%	+$384K	﹤0.01%	497
2022 Q1	$306K	Buy	8,425 +525	+7%	+$20.7K	﹤0.01%	602
2021 Q4	$368K	Buy	+7,900	New	+$401K	﹤0.01%	547

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s LEGN Position: Q2 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) reduced its Legend Biotech (LEGN) stake by 49% in Q2 2026, selling an estimated $213K and leaving 8,316 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in LEGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $964K in Q2 2022. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Caisse de Depot et Placement du Quebec (CDPQ) held 8,316 shares of Legend Biotech worth $240K as of Q2 2026.
Caisse de Depot et Placement du Quebec (CDPQ) sold 7,900 Legend Biotech shares in Q2 2026, an estimated $213K.
Legend Biotech made up ﹤0.01% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q2 2026, its #701 holding.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Legend Biotech in Q4 2021 and has held it in 10 quarters since.
Caisse de Depot et Placement du Quebec (CDPQ)'s Legend Biotech position peaked at $964K in Q2 2022.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2026, filed 14 Aug 2026.